Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Psychological Medicine

• Publication date

  2010-10-08

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1017/S0033291710001911PMID 20932356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Accumulation of major depressive episodes over time in a prospective study indicates that retrospectively assessed lifetime prevalence estimates are too low

  2009cited by this paper
• Depressive symptom profiles and severity patterns in outpatients with psychotic vs nonpsychotic major depression.

  2008cited by this paper
• Cognitive–behavioural therapy v. usual care in recurrent depression

  2008cited by this paper
• Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression.

  2008cited by this paper
• Differences in depressive symptom profile between males and females.

  2008influential reference
• Major Depression Symptoms in Primary Care and Psychiatric Care Settings: A Cross-Sectional Analysis

  2007cited by this paper
• Enhanced treatment for depression in primary care: long-term outcomes of a psycho-educational prevention program alone and enriched with psychiatric consultation or cognitive behavioral therapy

  2007cited by this paper
• Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.

  2007cited by this paper
• Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression.

  2006cited by this paper
• Propagation of major depressive disorder: relationship between first episode symptoms and recurrence.

  2006cited by this paper
• Stability of DSM-IV criterion symptoms for major depressive disorder.

  2005cited by this paper
• Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial

  2005cited by this paper
• Six-year outcome of cognitive behavior therapy for prevention of recurrent depression.

  2004cited by this paper
• The US National Comorbidity Survey Replication (NCS‐R): design and field procedures

  2004cited by this paper
• Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?

  2000cited by this paper
• Exercise Treatment for Major Depression: Maintenance of Therapeutic Benefit at 10 Months

  2000cited by this paper
• Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.

  2000cited by this paper
• Distributed disturbances in brain structure and function in schizophrenia.

  2000cited by this paper
• Empirical examination of current depression categories in a population-based study: symptoms, course, and risk factors.

  2000influential reference
• Background information and treatment recommendations for patients with HIV/AIDS

  2000cited by this paper
• Gender differences in chronic major and double depression.

  2000cited by this paper
• Prevention of relapse in residual depression by cognitive therapy: a controlled trial.

  1999cited by this paper
• Effects of exercise training on older patients with major depression.

  1999cited by this paper
• Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

  1998cited by this paper
• Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings.

  1998cited by this paper
• Residual symptoms after partial remission: an important outcome in depression

  1995cited by this paper
• THE COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW (CIDI)

  1994cited by this paper
• Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review.

  1994cited by this paper
• Outcome of depression and anxiety in primary care. A three-wave 3 1/2-year study of psychopathology and disability.

  1993cited by this paper
• Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment.

  1992cited by this paper

• Understanding cognitive dysfunction in depression: perspectives and practices of UK health and social care professionals, a qualitative study

  2026cites this paper
• Mental health promotion through soccer in high-risk communities: a narrative review

  2026cites this paper
• Cognitive impairment in comorbid MDD and OSA: the dual effects of intermittent hypoxia and sleep fragmentation

  2026cites this paper
• Sleep, Steps, and Screens: Between- and within-person effects of digital markers of daily life behaviors on smartphone-based assessments of cognitive functioning in depression.

  2026cites this paper
• The Comparative Efficacy of Antidepressant and Psychological Therapies on Cognition in Depression: A Systematic Review and Network Meta-Analysis.

  2025cites this paper
• Longitudinal trajectories of subjective cognitive complaints in patients with major depressive disorder and similar objective cognitive trajectories

  2025cites this paper
• Computational biological analysis reveals that HIF-1 and FoxO signaling pathways influence cognitive impairment in patients with depression

  2025cites this paper
• Effects of exercise training on cognition in adults with depression: A systematic review and three-level meta-analysis.

  2025cites this paper
• Cognitive Dysfunction and Learning Implications in Medical Students With Depressive Symptoms: Electrophysiological Evidence From P300 Event-Related Potentials

  2025cites this paper
• From Stress to Synapse: The Neuronal Atrophy Pathway to Mood Dysregulation

  2025cites this paper
• Neurocognitive Effects of Theta Burst Stimulation for Treatment-Resistant Depression in Adults: A Systematic Review and Recommendations for Future Research

  2025cites this paper
• Association Between Early Childhood P300 Deficits and Risk for Preadolescence Depressive Disorder Mediated by Responsiveness to PCIT-ED Treatment

  2025cites this paper
• Cognitive function in physically healthy, unmedicated individuals with major depression: Relationship with depressive symptoms and antidepressant response.

  2025cites this paper
• Serum homocysteine showed potential association with cognition and abnormal gut microbiome in major depressive disorder

  2025cites this paper
• Characteristics and clinical correlates of persistent anhedonia in the remitted patients with bipolar depression.

  2025cites this paper
• A new perspective on cognitive impairment in major depressive disorder: Changes in gut microbiota and their inflammatory regulatory mechanisms.

  2025cites this paper
• Effects on hippocampal activity following 5-HT4 receptor agonism in unmedicated patients with depression: the RESTAND study

  2025cites this paper
• Cognitive impairment and associated factors among patients with mood disorders receiving care at public hospitals in Gedeo zone, Southern Ethiopia.

  2025cites this paper
• Lateral habenula astroglia modulate the potentiating antidepressant-like effects of bright light stimulation in intractable depression

  2025cites this paper
• Identification of cognitive predictors of remission in depression following limited effect of repetitive transcranial magnetic stimulation on hot and cold cognitive systems

  2025cites this paper
• Home-use transcranial direct current stimulation (tDCS) as a safe, effective, and feasible application in depression: A randomized, single-blind, placebo-controlled trial

  2025cites this paper
• Reduced mind-wandering and fewer depressive symptoms associated with damage to the medial prefrontal cortex and default mode network.

  2025cites this paper
• The Effect of Brief Group Psychoeducation on Cognitive Distortions, Automatic Thoughts and Functioning in Major Depressive Disorder: A Randomized Controlled Trial.

  2025cites this paper
• Pro-cognitive effects of 5-HT4 receptor agonism in individuals with remitted depression

  2025cites this paper
• The Association Between Cognitive Functioning and Depression Severity: A Multiwave Longitudinal Remote Assessment Study

  2025cites this paper
• Clustering and drivers of symptoms observed at week six after antidepressant treatment in depressed outpatients

  2025cites this paper
• Successful mood repair in the laboratory predicts successful mood repair in daily life for typical but not for depression-prone young adults.

  2025cites this paper
• Effects of Chronic Exercise on Different Central Features of Depression in Adults with Depression: A Systematic Review and Meta-Analysis of Random Controlled Trials.

  2025cites this paper
• The impact of adolescent clinical depression and depressive symptoms on moral thinking: based on process dissociation approach

  2025cites this paper
• A new method for identifying and evaluating depressive disorders in young people based on cognitive neurocomputing: an exploratory study

  2025cites this paper
• The relationship between changes in white matter microstructure and cognition in untreated major depressive disorder.

  2025cites this paper
• A machine learning-based discriminative framework for mild cognitive impairment risk in middle-aged and elderly Chinese patients with depression: evidence from CHARLS and CLHLS.

  2025cites this paper
• A novel butyrylcholinesterase inhibitor induces antidepressant, pro-cognitive, and anti-anhedonic effects in Flinders Sensitive Line rats: The role of the ghrelin-dopamine cascade.

  2025cites this paper
• Association between Electroencephalographic microstates abnormalities and cognitive dysfunction in drug-naive MDD.

  2025cites this paper
• Cognitive and motor disturbances in depression: insights from comprehensive behavioral assessments

  2025cites this paper
• A heart rate variability-driven framework for depression screening leveraging emotion-elicited autonomic divergence

  2025cites this paper
• Predictors of Improvement in Subjective Executive Functioning Following an Internet-Delivered Cognitive Enhancement Intervention for Adults in Remission From Depression.

  2025cites this paper
• Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with tre

  2025cites this paper
• Depression Remission Over Six Months Characterized by Elevated Target‐Locked P300 ERP Component: Prospective Evidence Employing an Affective Visual Oddball Task

  2025cites this paper
• Major depressive disorder is characterized by differential theta and alpha patterns during working memory updating

  2025cites this paper
• Model-based planning is unaffected by ketamine, antidepressant and internet delivered cognitive behavioural therapy treatments in depression

  2025cites this paper
• Cross-sectional and longitudinal associations between subthreshold depressive symptoms and cognition, physical health, and quality of life in older adults aged 55+: a retrospective study.

  2025cites this paper
• Association between social cognition, depressive symptoms and resilience among elderly people.

  2025cites this paper
• Research on the Immune Mechanisms of Cognitive Impairment in Depression

  2025cites this paper
• Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases

  2024cites this paper
• Validation of Machine Learning-Based Assessment of Major Depressive Disorder from Paralinguistic Speech Characteristics in Routine Care

  2024cites this paper
• Association of performance in medical residency selection with a psychiatric diagnosis, and depressive and anxiety symptoms

  2024cites this paper
• Acute treatment residual depression symptoms and functional impairment among depressive patients of different age groups and education levels in China: A prospective, multicenter, randomized study

  2024cites this paper
• Association of cardiovascular health with cognitive function and the mediating effect of depressive state

  2024cites this paper
• Development of a multivariate prediction model for antidepressant resistant depression using reward-related predictors

  2024cites this paper
• VGLUT2 may improve cognitive function in depressed rats by protecting prefrontal cortex neurons

  2024cites this paper
• Understanding the multiple dimensions of ageing: 5Ms for the rheumatologist.

  2024cites this paper
• The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges

  2024cites this paper
• The prevalence and clinical correlation factors of cognitive impairment in patients with major depressive disorder hospitalized during the acute phase

  2024cites this paper
• Not Just a Mood Disorder—Is Depression a Neurodevelopmental, Cognitive Disorder? Focus on Prefronto-Thalamic Circuits

  2024cites this paper
• Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain

  2024cites this paper
• Six-year course over time and predictors of suicidal ideation in depressed older patients.

  2024cites this paper
• The Nature of Mental Imagery and Its Relationship With Amotivational Psychopathology in People With Schizophrenia Spectrum Disorders.

  2024cites this paper
• Clinical and Psychological Factors Associated with Frailty in Patients with Heart Failure

  2024cites this paper
• Assessing remission in major depressive disorder using a functional-structural data fusion pipeline: A CAN-BIND-1 study

  2024cites this paper
• Exploring the Impact of Cognitive Dysfunction During Recurrent Depression in a Sample of Mid‐to‐Older Age British South Asians: A Qualitative Study

  2024cites this paper
• Investigating the shared genetic architecture between depression and subcortical volumes

  2024cites this paper
• Pharmacotherapy guideline concordance for major depressive disorder and its link to functioning via symptom change

  2024cites this paper
• Association between Life's essential 8 and incident cardiovascular disease among individuals with depression: a prospective study.

  2024cites this paper
• Evaluating an EEG-based tool for assessing acute clinical and cognitive changes in adult outpatients with MDD treated with open-label, flexible-dose vortioxetine: A pilot study

  2024cites this paper
• Cognitive function characteristics and influencing factors in patients with depressive disorders: a 5-year follow-up report based on the epidemiological survey of mental disorders in Shandong Province, China

  2024cites this paper
• Efficacy of an internet-delivered cognitive enhancement intervention for subjective residual cognitive deficits in remitted major depressive disorder: A randomized crossover trial.

  2024cites this paper
• Identifying the core residual symptom in patients with major depressive disorder using network analysis and illustrating its association with prognosis: A study based on the national cohorts in China.

  2024cites this paper
• Associations between white matter microstructure and cognitive decline in major depressive disorder versus controls in Germany: a prospective case-control cohort study.

  2024cites this paper
• Electroconvulsive Therapy (ECT): A Scotland Wide Naturalistic Study of 4,826 treatment episodes

  2024cites this paper
• Treating Depression to Improve Survival in Coronary Heart Disease: What Have We Learned?

  2024cites this paper
• Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study

  2024cites this paper
• Comparison of networks of loneliness, depressive symptoms, and anxiety symptoms in at-risk community-dwelling older adults before and during COVID-19

  2024cites this paper
• Electroconvulsive Therapy: A Scotland-Wide Naturalistic Study of 4826 Treatment Episodes

  2024cites this paper
• Cognitive Dysfunction in Unipolar Depression.

  2024cites this paper
• Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine

  2024influential citation
• Adult Neurogenesis, Context Encoding, and Pattern Separation: A Pathway for Treating Overgeneralization.

  2024cites this paper
• Exploring the neurocognitive correlates of suicidal ideation in major depressive disorder: The role of frontoparietal and default mode networks.

  2024cites this paper
• The interplay between polygenic score for tumor necrosis factor-α, brain structural connectivity, and processing speed in major depression

  2024cites this paper
• Sleep disturbances and psychomotor retardation in the prediction of cognitive impairments in patients with major depressive disorder

  2024cites this paper
• The functional role of the pulvinar in discriminating between objective and subjective cognitive impairment in major depressive disorder

  2024cites this paper
• Depressive Symptoms Are Not Associated with Predementia Cerebrospinal Fluid Amyloid Pathology

  2024cites this paper
• Association of cognitive impairment with the interaction between chronic kidney disease and depression: findings from NHANES 2011–2014

  2024cites this paper
• The dose-response relationship of vortioxetine on major depressive disorder: an umbrella review.

  2024cites this paper
• Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities.

  2024cites this paper
• The longitudinal change pattern of cognitive subtypes in medication-free patients with major depressive disorder: a cluster analysis.

  2023cites this paper
• Distorted thoughts as a mediator of depressive symptoms in patients with major depressive disorder: a longitudinal study

  2023cites this paper
• Perceived cognitive impairment is related to internalizing psychopathology but unrelated to objective cognitive performance among nongeriatric adults presenting for outpatient neuropsychological evaluation

  2023cites this paper
• Long-term outcomes of an internet-delivered cognitive enhancement intervention targeting residual cognitive deficits after major depressive disorder: a 2-year follow-up of an open trial

  2023cites this paper
• Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder

  2023cites this paper
• The conscious processing of emotion in depression disorder: a meta-analysis of neuroimaging studies

  2023cites this paper
• Do depressed patients really over-report cognitive impairment?

  2023cites this paper
• Immune gene co-expression signatures implicated in occurence and persistence of cognitive dysfunction in depression.

  2023cites this paper
• Improvement in self-reported cognitive functioning but not in rumination following online working memory training in a two-year follow-up study of remitted major depressive disorder

  2023cites this paper
• The impact of depressive symptomology, rumination and objective memory performance on subjective cognitive complaints.

  2023cites this paper
• A CROSS-SECTIONAL SURVEY OF AUSTRALIAN WOMEN'S PERSPECTIVES AND EXPERIENCES OF EXERCISE DURING PREGNANCY, INCLUDING WOMEN THAT EXPERIENCE MENTAL ILLNESS

  2023cites this paper
• Prevalence and correlates of subjective cognitive impairment in Chinese psychiatric patients during the fifth wave of COVID-19 in Hong Kong

  2023cites this paper
• Internet addiction and residual depressive symptoms among clinically stable adolescents with major psychiatric disorders during the COVID-19 pandemic: a network analysis perspective

  2023cites this paper
• Cognitive performance and brain structural connectome alterations in major depressive disorder

  2023cites this paper
• Trying to name what doesn't change: Neural nonresponse to Cognitive Therapy for depression.

  2023cites this paper